Cholangiocarcinoma
Cholangiocarcinoma
Definition
A carcinoma that arises from the intrahepatic biliary tree (intrahepatic cholangiocarcinoma) or from the junction, or adjacent to the junction, of the right and left hepatic ducts (hilar cholangiocarcinoma). Grossly, the malignant lesions are solid, nodular, and grayish. Morphologically, the vast majority of cases are adenocarcinomas. Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats. Early detection is difficult and the prognosis is generally poor.
Also known as CC, CCA, Cholangiocar.- intra/extrahepatic, cholangiocarcinoma, cholangiocarcinoma, intrahepatic and extrahepatic bile ducts (adenocarcinoma), cholangiocarcinoma, malignant, Cholangiocellular carcinoma — per MONDO
Also identified as
- DOID 4947 per MONDO
- MESH D018281 per MONDO
- NCIT C4436 per MONDO
- Orphanet 70567 per MONDO
- SCTID 312104005 per MONDO
- UMLS C0206698 per MONDO
Affected Organs
| Organ | Involvement | Source |
|---|---|---|
| Alimentary part of gastrointestinal system | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Alimentary part of gastrointestinal system | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
| Bile ducts | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Bile ducts | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
| Biliary system | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Biliary system | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
Drugs indicated
| Drug | Relation | Source |
|---|---|---|
| Futibatinib | may treat | MEDRT · Public domain (U.S. Government work) |
| Pemigatinib | may treat | MEDRT · Public domain (U.S. Government work) |